Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
AcelRx Pharmaceuticals Stock Price (Quote) NASDAQ:ACRX
$0.26 ( -11.83% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.16 | $0.31 | Friday, 20th May 2022 ACRX stock ended at $0.26. This is 11.83% less than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 18.87% from a day low at $0.25 to a day high of $0.30. |
| 90 days | $0.16 | $0.48 | |
| 52 weeks | $0.16 | $1.67 |
Historical AcelRx Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $0.29 | $0.30 | $0.25 | $0.26 | 1 499 523 |
| 2022-05-19 | $0.23 | $0.31 | $0.23 | $0.29 | 4 014 051 |
| 2022-05-18 | $0.22 | $0.23 | $0.22 | $0.23 | 565 269 |
| 2022-05-17 | $0.22 | $0.22 | $0.21 | $0.22 | 388 523 |
| 2022-05-16 | $0.19 | $0.21 | $0.19 | $0.21 | 667 786 |
| 2022-05-13 | $0.22 | $0.22 | $0.18 | $0.21 | 1 192 980 |
| 2022-05-12 | $0.19 | $0.19 | $0.16 | $0.18 | 1 523 726 |
| 2022-05-11 | $0.20 | $0.21 | $0.18 | $0.19 | 1 313 868 |
| 2022-05-10 | $0.23 | $0.24 | $0.20 | $0.21 | 1 380 723 |
| 2022-05-09 | $0.24 | $0.24 | $0.21 | $0.21 | 1 067 791 |
| 2022-05-06 | $0.22 | $0.25 | $0.21 | $0.25 | 1 968 223 |
| 2022-05-05 | $0.23 | $0.24 | $0.20 | $0.21 | 1 007 506 |
| 2022-05-04 | $0.24 | $0.25 | $0.22 | $0.22 | 982 135 |
| 2022-05-03 | $0.25 | $0.26 | $0.23 | $0.23 | 791 100 |
| 2022-05-02 | $0.26 | $0.26 | $0.24 | $0.24 | 480 911 |
| 2022-04-29 | $0.24 | $0.25 | $0.24 | $0.25 | 695 439 |
| 2022-04-28 | $0.25 | $0.25 | $0.23 | $0.24 | 632 139 |
| 2022-04-27 | $0.24 | $0.26 | $0.23 | $0.24 | 678 811 |
| 2022-04-26 | $0.24 | $0.25 | $0.22 | $0.24 | 825 995 |
| 2022-04-25 | $0.24 | $0.25 | $0.24 | $0.24 | 460 159 |
| 2022-04-22 | $0.25 | $0.25 | $0.23 | $0.24 | 201 346 |
| 2022-04-21 | $0.25 | $0.26 | $0.24 | $0.24 | 764 900 |
| 2022-04-20 | $0.26 | $0.27 | $0.25 | $0.26 | 397 500 |
| 2022-04-19 | $0.26 | $0.28 | $0.24 | $0.27 | 1 147 100 |
| 2022-04-18 | $0.26 | $0.26 | $0.25 | $0.25 | 844 700 |
| 2022-04-14 | $0.28 | $0.28 | $0.25 | $0.26 | 956 520 |
| 2022-04-13 | $0.27 | $0.28 | $0.26 | $0.27 | 849 445 |
| 2022-04-12 | $0.27 | $0.27 | $0.25 | $0.27 | 895 864 |
| 2022-04-11 | $0.27 | $0.28 | $0.25 | $0.27 | 1 814 968 |
| 2022-04-08 | $0.27 | $0.28 | $0.27 | $0.27 | 369 151 |
| 2022-04-07 | $0.30 | $0.30 | $0.27 | $0.27 | 588 300 |
| 2022-04-06 | $0.29 | $0.29 | $0.27 | $0.28 | 909 700 |
| 2022-04-05 | $0.29 | $0.32 | $0.28 | $0.29 | 1 866 700 |
| 2022-04-04 | $0.30 | $0.30 | $0.28 | $0.29 | 592 100 |
| 2022-04-01 | $0.29 | $0.30 | $0.28 | $0.28 | 1 031 299 |
| 2022-03-31 | $0.28 | $0.29 | $0.28 | $0.29 | 1 007 097 |
| 2022-03-30 | $0.30 | $0.30 | $0.25 | $0.29 | 4 021 141 |
| 2022-03-29 | $0.30 | $0.32 | $0.27 | $0.28 | 5 117 493 |
| 2022-03-28 | $0.31 | $0.32 | $0.29 | $0.30 | 1 844 200 |
| 2022-03-25 | $0.32 | $0.33 | $0.31 | $0.32 | 570 400 |
| 2022-03-24 | $0.32 | $0.34 | $0.31 | $0.32 | 1 414 200 |
| 2022-03-23 | $0.33 | $0.34 | $0.32 | $0.32 | 987 900 |
| 2022-03-22 | $0.34 | $0.36 | $0.32 | $0.33 | 1 105 957 |
| 2022-03-21 | $0.35 | $0.35 | $0.32 | $0.33 | 825 151 |
| 2022-03-18 | $0.35 | $0.38 | $0.32 | $0.32 | 1 188 997 |
| 2022-03-17 | $0.34 | $0.36 | $0.34 | $0.36 | 932 300 |
| 2022-03-16 | $0.32 | $0.34 | $0.31 | $0.33 | 820 600 |
| 2022-03-15 | $0.31 | $0.32 | $0.30 | $0.31 | 911 000 |
| 2022-03-14 | $0.35 | $0.35 | $0.29 | $0.32 | 2 033 600 |
| 2022-03-11 | $0.38 | $0.40 | $0.32 | $0.34 | 2 962 200 |
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain in the United States. The companys lead product candidates include ARX-04, a sufentanil sublingual tablet that is in Phase III clinical trials for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings; and Zalviso, a sufentan... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
